Alpha-fetoprotein (AFP) is one of the most common serum markers in the diagnosis of HCC, and its high expression in hepatocellular carcinoma cells makes it a promising target for vaccine-based therapy (92). This evidence concerns the gene AFP and hepatocellular carcinoma.